ORLANDO, Fla.—Infusion with the investigational compound brexanolone outperformed selective serotonin reuptake inhibitors (SSRIs) for the treatment of postpartum depression, according to a study presented at Psych Congress 2018.
SAN FRANCISCO—Machine learning shows potential for predicting postpartum depression using clinical data routinely collected in electronic health records, according to a study presented during a poster session at the American Psychiatric Association’s annual meeting.
By Lisa Rapaport
Growing numbers of new mothers are being diagnosed with depression before they leave the hospital with their newborns, according to a U.S. study that suggests screening women at childbirth could help get treatment for those who…
Behavioral health care must be better integrated with physical health care during and after pregnancy to sufficiently meet the needs of women with perinatal mood and anxiety disorders (PMADs), Mousumi Mukerji, MSN, PMHNP-BC, CNM, said at Elevate by Psych Congress.
In this video, Marlene Freeman, MD, discusses tools for detecting postpartum depression, how postpartum depression differs from other mental health disorders, and risk factors for postpartum depression.